Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory (Q44720497)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 23, 2011

Language	Label	Description	Also known as
English	Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory	scientific article published on July 23, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory (English)

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mohit Khera

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Gary Blick

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Harvey Kushner

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dat Nguyen

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Rajib K. Bhattacharya

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21788049

8 December 2024

Martin M. Miner

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21788049

8 December 2024

language of work or name

0 references

publication date

23 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534711038468?httpAccept=text/xml

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

https://api.elsevier.com/content/article/PII:S0022534711038468?httpAccept=text/plain

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

http://www.jurology.com/doi/pdf/10.1016/j.juro.2011.04.065

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

186

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1005-1011

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Patient information page from The Hormone Foundation. Patient guide to testosterone therapy in adult men with androgen deficiency syndromes

1

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

2

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices

3

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Male hypogonadism : an update on diagnosis and treatment

4

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Testosterone replacement therapy and the risk of prostate cancer. Is there a link?

5

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?

7

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males

8

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies

9

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

10

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer

11

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

12

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

13

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Association of specific symptoms and metabolic risks with serum testosterone in older men

15

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

16

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system

18

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

20

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

22

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

23

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

25

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.

26

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

27

1 reference

10.1016/J.JURO.2011.04.065

https://api.crossref.org/works/10.1016/J.JURO.2011.04.065

8 December 2024

Identifiers

10.1016/J.JURO.2011.04.065

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44720497&oldid=2284736328"